Botulinum toxin A injection before hemorrhoid surgery to reduce postoperative pain
Official title: Effect of Internal Anal Sphincter Botulinum Toxin A Injection 7 Days Before Hemorrhoidectomy on Postoperative Pain: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Run by Lomonosov Moscow State University Medical Research and Educational Center · NCT07399860 · Data updated 2026-11-12
This study will see if injecting botulinum toxin A into the internal anal sphincter a week before hemorrhoidectomy reduces post-operative pain for adults with grade III–IV hemorrhoids.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 292 (estimated) |
| Sponsor | Lomonosov Moscow State University Medical Research and Educational Center Academic / other |
| Locations | 1 site (Moscow, Moscow) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | January 2027 |
| Study ends | January 2028 |
| Registry record updated | March 10, 2026 |
| Trial ID | NCT07399860 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with symptomatic grade III–IV hemorrhoids scheduled for open (Milligan-Morgan) or closed (Ferguson) excisional hemorrhoidectomy and without contraindications to botulinum toxin are ideal candidates.
✕Probably not a fit
Patients with prior anal sphincter surgery, baseline fecal incontinence, neuromuscular junction disorders, active anorectal infection or inflammatory bowel disease in the active phase, pregnancy or breastfeeding, or those who cannot safely stop anticoagulation are unlikely to receive benefit and are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind, placebo-controlled Phase 2 trial gives adult patients with symptomatic grade III–IV hemorrhoids either botulinum toxin A or saline injected into the internal anal sphincter seven days before excisional hemorrhoidectomy. Injections are performed in four quadrants using a standardized technique and both patients and surgeons are blinded to allocation. All participants undergo open or closed hemorrhoidectomy with standardized perioperative care, and postoperative pain is measured with a visual analogue scale during the first seven days. Secondary outcomes include analgesic use, complications, length of stay, transient fecal incontinence, time to first bowel movement, readmissions, and patient satisfaction within 30 days.
Why it matters
Potential benefit: If successful, preoperative botulinum toxin A could reduce postoperative pain, lower analgesic needs, and speed recovery after hemorrhoidectomy.
How similar studies have gone: Botulinum toxin A has proven effective for anal sphincter spasm and chronic anal fissure, but its preoperative use to reduce pain after hemorrhoidectomy is less well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults ≥18 years, male and female * Symptomatic grade III-IV hemorrhoidal disease (Goligher), refractory to conservative treatment * Scheduled for open (Milligan-Morgan) or closed (Ferguson) hemorrhoidectomy Exclusion Criteria: * Known hypersensitivity to botulinum toxin A, human albumin, or local anesthetics. * Neuromuscular junction disorders (e.g., myasthenia gravis, Lambert-Eaton syndrome). * Use of aminoglycosides or other agents interfering with neuromuscular transmission within 14 days. * Coagulopathy or ongoing anticoagulant therapy not suitable for perioperative interruption. * Active anorectal infection, fissure, abscess, or inflammatory bowel disease in the active phase. * Previous anal sphincter surgery or baseline fecal incontinence. * Pregnancy or breastfeeding. * ASA ≥ III or significant systemic disease compromising anesthesia or wound healing. * Participation in another interventional clinical trial within 30 days.
Where it's running
-
Lomonosov Moscow State University Medical Research and Educational Center
Moscow, Moscow, Russia Recruiting
Study contacts
- Study coordinator: Tatiana Garmanova, MD, PhD
- Email: tatianagarmanova@gmail.com
- Phone: + 7 977 342 92 49
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
Palatal Shield Technique to Reduce Pain and Improve Healing After Free Gingival Graft
This randomized trial tests whether a collagen sponge with a protective palatal shield made of flowable resin helps reduce pain and improve healing after free gingival graft harvest.
-
Perfusion Index to Measure Postoperative Pain in Kids After Adenotonsillectomy
This study tests whether the perfusion index can reliably reflect pain levels in children aged 1–12 after adenotonsillectomy, comparing standard care with an added glossopharyngeal nerve block.
-
Anterior Knee Nerves Block vs Femoral Nerve Block for Knee Arthroscopy
This trial tests whether an anterior nerves of the knee (ANK) block provides similar pain relief to a femoral nerve block after knee arthroscopy in adults, aiming to reduce quadriceps weakness.
-
Natural Biopolymer-Based Irrigant for Root Canal Cleaning
This trial tests a chitosan nanoparticle irrigant to improve cleaning and disinfection in single-rooted teeth with asymptomatic pulp necrosis undergoing endodontic treatment.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.